BioSpace News Archive

DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for its fiscal third quarter ended June 30, 2022 on August 2, 2022 after the market closes.

SeaStar Medical and LMF Acquisition Opportunities, Inc. today announced SeaStar Medical has submitted its application to the U.S. Food and Drug Administration (“FDA”) for Humanitarian Device Exemption (HDE).

ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on Chronic Kidney Disease (CKD), announces the appointment of nephrologist Kerry Cooper, M.D. as Senior Vice President of Medical Affairs.

Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its second quarter 2022 financial performance in a press release before the market opens on Monday, August 8, 2022.

Eiger BioPharmaceuticals Inc. announced today the European Commission (EC) has granted marketing authorization for Zokinvy® (lonafarnib), a first-in-class breakthrough therapy for children and young adults with Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PL).

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was recognized as a Best Place to Work for Disability Inclusion.

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management, announced that the company will be participating in two upcoming investor conferences.